Details for New Drug Application (NDA): 017769
✉ Email this page to a colleague
NDA 017769 describes CALCIMAR, which is a drug marketed by Sanofi Aventis Us and is included in two NDAs. Additional details are available on the CALCIMAR profile page.
The generic ingredient in CALCIMAR is calcitonin salmon. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
The generic ingredient in CALCIMAR is calcitonin salmon. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Summary for 017769
| Tradename: | CALCIMAR |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | calcitonin salmon |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200 IU/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
